ENOV Logo

Enovis Corporation (ENOV) 

NYSE
Market Cap
$2.42B
Sector
Industrials
Industry
Industrial—Machinery
Rank in Sector
402 of 524
Rank in Industry
50 of 64

Largest Insider Buys in Sector

ENOV Stock Price History Chart

ENOV Stock Performance

About Enovis Corporation

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold …

Insider Activity of Enovis Corporation

Over the last 12 months, insiders at Enovis Corporation have bought $0 and sold $0 worth of Enovis Corporation stock.

On average, over the past 5 years, insiders at Enovis Corporation have bought $5.99M and sold $16.03M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 62,500 shares for transaction amount of $2.9M was made by RALES MITCHELL P (director) on 2021‑08‑04.

List of Insider Buy and Sell Transactions, Enovis Corporation

2023-08-07SalePrincipal Accounting Officer
174
0.0003%
$59.18$10,297-8.54%
2023-07-20SalePrincipal Accounting Officer
67
0.0001%
$65.32$4,376-15.92%
2023-06-02SaleSVP, Chief Financial Officer
645
0.0011%
$54.17$34,940-0.02%
2023-05-08Saledirector
1,396
0.0026%
$57.18$79,823-1.00%
2023-04-03SalePres. & COO
695
0.0013%
$53.54$37,210+5.69%
2023-03-20SaleSVP, Chief Financial Officer
600
0.0011%
$51.84$31,104+9.35%
2023-03-16Saledirector
2,793
0.005%
$52.13$145,585+5.33%
2023-03-06SalePresident & CEO
6,743
0.0125%
$57.69$389,004-2.10%
2023-03-06SaleEVP, Strategy & Business Dev.
1,898
0.0035%
$57.69$109,496-2.10%
2023-03-06SalePres. & COO
2,102
0.0039%
$57.69$121,264-2.10%
2023-03-06SaleSVP, Chief HR Officer
745
0.0014%
$57.69$42,979-2.10%
2023-03-06SaleSVP, General Counsel
1,092
0.002%
$57.69$62,997-2.10%
2023-02-27SalePresident & CEO
18,917
0.0342%
$56.21$1.06M-2.39%
2023-02-27SaleEVP, Strategy & Business Dev.
5,716
0.0103%
$56.08$320,553-2.39%
2023-02-27SalePres. & COO
8,156
0.0147%
$56.07$457,307-2.39%
2023-02-27SaleSVP, Chief HR Officer
1,963
0.0035%
$56.09$110,105-2.39%
2023-02-27SaleSVP, General Counsel
2,491
0.0045%
$56.08$139,695-2.39%
2023-02-23SalePresident & CEO
3,945
0.0069%
$54.62$215,476-3.13%
2023-02-23SaleEVP, Strategy & Business Dev.
1,113
0.0019%
$54.61$60,781-3.13%
2023-02-23SalePres. & COO
1,232
0.0022%
$54.63$67,304-3.13%

Insider Historical Profitability

5.09%
RALES STEVEN M10 percent owner
11296361
20.217%
$43.2410+6.14%
RALES MITCHELL Pdirector
1170201
2.0943%
$43.24140+1.09%
PRYOR DANIEL AEVP, Strategy & Business Dev.
108291
0.1938%
$43.24119<0.0001%
Shirley BradyPres. & COO
61291
0.1097%
$43.2417+64.66%
Clark Lynn HSVP - Global Human Resources
35662
0.0638%
$43.2416<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
T Rowe Price Investment Management Inc$411.49M12.016.59M+0.1%+$432,279.900.25
BlackRock$333.16M9.735.33M+0.07%+$230,440.500.01
The Vanguard Group$305.64M8.924.89M-0.13%-$406,861.750.01
Dimensional Fund Advisors$199.51M5.823.19M+0.03%+$64,510.850.05
Diamond Hill Investment Group Inc$152M4.442.43M-2.87%-$4.5M0.62
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.